)
Jeena Sikho Lifecare (JSLL) investor relations material
Jeena Sikho Lifecare Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Unaudited standalone and consolidated results for the quarter ended 30 June 2026 were approved by the Board after Audit Committee review.
Revenue and PAT rose YoY on standalone and consolidated bases; Q1FY27 revenue from operations was ₹22,440.48 lakh standalone and consolidated.
Growth reflected patient-volume gains, an expanding care network and 47% YoY growth in Ayurveda products; the footprint included 62 hospitals, 57 clinics and day-care centres, and 2,400 operational beds.
Financial highlights
Standalone revenue from operations was ₹22,440.48 lakh vs ₹17,428.59 lakh YoY; PAT was ₹6,569.18 lakh vs ₹5,131.14 lakh.
Consolidated revenue from operations was ₹22,440.48 lakh vs ₹17,428.59 lakh YoY; PAT was ₹6,589.01 lakh vs ₹5,127.14 lakh.
Consolidated profit before tax was ₹8,752.99 lakh vs ₹6,850.98 lakh; total income was ₹23,873.13 lakh vs ₹17,535.44 lakh.
Revenue rose 4% QoQ and 29% YoY; EBITDA was ₹9,211 lakh, up 18% QoQ and 17% YoY, while EBIT was ₹7,679 lakh, up 25% QoQ and 11% YoY.
PAT rose 45% QoQ and 28% YoY; other income was ₹1,402 lakh versus ₹358 lakh QoQ and ₹107 lakh YoY, while finance cost rose 109% YoY to ₹347 lakh.
Outlook and guidance
Around 2,400 operational beds and 450 beds in the pipeline support planned capacity-led and volume-led growth over the medium term.
A first wellness resort was signed in Manali, with plans for 108 rooms, 22 villas, a helipad and access to 20+ acres of private forest.
Planned product categories include plant-based protein, gynaecology and joint-care products; new pharmacy-channel launches are in progress.
Derabassi hospital property sale for ₹9.05 crore is expected to close by 30 September 2026; operations are planned to continue at the same premises under a proposed lease.
Derabassi contributes ~6%–8% of revenue; the sale is not expected to materially affect operations or revenue generation.
- H1 revenue, profit and operating cash flow all advanced year over year.JSLL
Q2 23/24 - FY23 revenue reached ₹204 crore as a 119-site network supported expansion.JSLL
Investor presentation - Asset-light Ayurveda services and product sales supported expansion and higher reported revenue.JSLL
Investor presentation - Q2 revenue grew 66% as margins, patient volumes and hospital capacity advanced.JSLL
Q2 25/26 - FY24 revenue grew 59% as profits doubled and operational capacity expanded.JSLL
Q4 23/24 - H1FY25 revenue and PAT rose as expansion costs weighed on EBITDA margin.JSLL
Q2 24/25 - FY25 revenue rose 45%, with 87% IPD growth as capacity expanded to 1,600 beds.JSLL
Q4 24/25 - Standalone Q3 revenue rose 92%, with PAT up 405% and 475+ beds in development.JSLL
Q3 25/26 - Revenue reached ₹17,428.59 lakh, with standalone PAT of ₹5,131.14 lakh.JSLL
Q1 25/26 - Consolidated FY26 net profit reached ₹22,169.81 lakh; proposed dividend is ₹4.50 per share.JSLL
Q4 25/26
Next Jeena Sikho Lifecare earnings date
Next Jeena Sikho Lifecare earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)